Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Retained Earnings (2019 - 2025)

Pliant Therapeutics (PLRX) has disclosed Retained Earnings for 7 consecutive years, with -$15000.0 as the latest value for Q4 2025.

  • Quarterly Retained Earnings rose 100.0% to -$15000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$15000.0 through Dec 2025, up 100.0% year-over-year, with the annual reading at -$15000.0 for FY2025, 100.0% up from the prior year.
  • Retained Earnings for Q4 2025 was -$15000.0 at Pliant Therapeutics, up from -$835.8 million in the prior quarter.
  • The five-year high for Retained Earnings was $345000.0 in Q4 2023, with the low at -$835.8 million in Q3 2025.
  • Average Retained Earnings over 5 years is -$213.1 million, with a median of -$2.2 million recorded in 2022.
  • The sharpest move saw Retained Earnings crashed 544950.0% in 2021, then surged 132.52% in 2025.
  • Over 5 years, Retained Earnings stood at -$201000.0 in 2021, then crashed by 874.13% to -$2.0 million in 2022, then soared by 117.62% to $345000.0 in 2023, then crashed by 205912.17% to -$710.1 million in 2024, then soared by 100.0% to -$15000.0 in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$15000.0, -$835.8 million, and -$809.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.